# The9 LTD: Form 20-F for the period ended Dec 31, 2021

- Company: [The9 LTD](/companies/ncty.md) (CIK 1296774)
- Form: 20-F
- Filed: 2022-05-02
- Accepted by EDGAR: May 2, 2022, 17:21 ET
- Period: 2021-12-31
- Accession: 0001410578-22-001128
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1296774/000141057822001128/ncty-20211231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1296774/000141057822001128/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-01-01 to 2021-12-31 | $21.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2021-01-01 to 2021-12-31 | $13.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2021-01-01 to 2021-12-31 | $7.5m | us-gaap:GrossProfit |
| Research and development | 12 months, 2021-01-01 to 2021-12-31 | $300.9k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2021-01-01 to 2021-12-31 | −$49.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2021-01-01 to 2021-12-31 | $18.7m | us-gaap:InterestExpense |
| Income tax | 12 months, 2021-01-01 to 2021-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2021-01-01 to 2021-12-31 | −$64.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2021-01-01 to 2021-12-31 | −$0.13 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2021-01-01 to 2021-12-31 | −$0.13 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2021-01-01 to 2021-12-31 | 495,304,894 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2021-01-01 to 2021-12-31 | −$107.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2021-12-31 | $67.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-12-31 | $164.8m | us-gaap:AssetsCurrent |
| Total assets | at 2021-12-31 | $205.6m | us-gaap:Assets |
| Current liabilities | at 2021-12-31 | $85.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-12-31 | $85.8m | us-gaap:Liabilities |
| Shareholders' equity | at 2021-12-31 | $121.8m | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1296774/000141057822001128/ncty-20211231x20f.htm

Filed May 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001410578-22-001128. Last ingested by Listed: Nov 2, 2026, 06:20 ET. No prices; not investment advice.
